» Articles » PMID: 35450364

SiRNAs with Neutral Phosphate Triester Hydrocarbon Tails Exhibit Carrier-Free Gene-Silencing Activity

Overview
Specialty Chemistry
Date 2022 Apr 22
PMID 35450364
Authors
Affiliations
Soon will be listed here.
Abstract

Short interfering RNAs (siRNAs) show promise as gene-silencing therapeutics, but their cellular uptake remains a challenge. We have recently shown the synthesis of siRNAs bearing a single neutral phenylethyl phosphotriester linkage within the sense strand. Here, we report the synthesis of siRNAs bearing three different hydrophobic phosphate triester linkages at key positions within the sense strand and assess their gene silencing in the absence of a transfection carrier. The best siRNAs bearing hydrophobic phosphate triester tails were not aromatic and exhibited effective gene silencing (IC ≈ 56-141 nM), whereas the aromatic derivative with three hydrophobic tails did not exhibit carrier-free gene silencing.

Citing Articles

Synthesis, Biophysical and Biological Evaluation of Splice-Switching Oligonucleotides with Multiple LNA-Phosphothiotriester Backbones.

Dhara D, Hill A, Ramesh A, Wood M, El-Sagheer A, Brown T J Am Chem Soc. 2024; 146(43):29773-29781.

PMID: 39401255 PMC: 11528411. DOI: 10.1021/jacs.4c11402.


Advancing New Chemical Modalities into Clinical Studies.

Blanco M, Gardinier K, Namchuk M ACS Med Chem Lett. 2022; 13(11):1691-1698.

PMID: 36385931 PMC: 9661701. DOI: 10.1021/acsmedchemlett.2c00375.

References
1.
Braasch D, Jensen S, Liu Y, Kaur K, Arar K, White M . RNA interference in mammalian cells by chemically-modified RNA. Biochemistry. 2003; 42(26):7967-75. DOI: 10.1021/bi0343774. View

2.
Tsubaki K, Shimooka H, Kitamura M, Okauchi T . Selective Transesterification of 2,2,2-Trifluoroethyl Phosphates: Synthesis of Mixed Unsymmetrical Phosphates. Org Lett. 2019; 21(23):9779-9783. DOI: 10.1021/acs.orglett.9b04003. View

3.
Noland C, Doudna J . Multiple sensors ensure guide strand selection in human RNAi pathways. RNA. 2013; 19(5):639-48. PMC: 3677279. DOI: 10.1261/rna.037424.112. View

4.
Shukla S, Sumaria C, Pradeepkumar P . Exploring chemical modifications for siRNA therapeutics: a structural and functional outlook. ChemMedChem. 2010; 5(3):328-49. DOI: 10.1002/cmdc.200900444. View

5.
Gavrilov K, Saltzman W . Therapeutic siRNA: principles, challenges, and strategies. Yale J Biol Med. 2012; 85(2):187-200. PMC: 3375670. View